MEDPAL AI is trading at £5.92, down 5.96%, as investors react to dilution concerns surrounding a £5 million share placing announced September 21, 2026.

  • The placing involves 100 million new shares at 5.0 pence each, approximately 17% below the September 18 closing price.
  • Proceeds will fund medication stock and GLP-1 automation; admission of the new shares is expected September 24, 2026.
  • The broader market is slightly firmer, making company-specific dilution the clearer driver.